BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23581013)

  • 21. Towards a metabolic therapy of cancer?
    Chiu M; Ottaviani L; Bianchi MG; Franchi-Gazzola R; Bussolati O
    Acta Biomed; 2012 Dec; 83(3):168-76. PubMed ID: 23762991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic switch and its regulation in cancer cells.
    Zhou S; Huang C; Wei Y
    Sci China Life Sci; 2010 Aug; 53(8):942-58. PubMed ID: 20821293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Warburg effect: from theory to therapeutic applications in cancer].
    Razungles J; Cavaillès V; Jalaguier S; Teyssier C
    Med Sci (Paris); 2013 Nov; 29(11):1026-33. PubMed ID: 24280507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The molecular function of oncogenes].
    Njølstad PR
    Tidsskr Nor Laegeforen; 1990 Nov; 110(28):3632-6. PubMed ID: 2260064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological aspects of neoplasms in diabetes.
    Nicolucci A
    Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process.
    Salminen A; Kaarniranta K
    J Cell Physiol; 2010 Jul; 224(1):1-6. PubMed ID: 20301205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic reprogramming of the tumor.
    Ferreira LM; Hebrant A; Dumont JE
    Oncogene; 2012 Sep; 31(36):3999-4011. PubMed ID: 22231450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.
    LeRoith D; Novosyadlyy R; Gallagher EJ; Lann D; Vijayakumar A; Yakar S
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S4-6. PubMed ID: 18777452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.
    Lunt SY; Vander Heiden MG
    Annu Rev Cell Dev Biol; 2011; 27():441-64. PubMed ID: 21985671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor growth by replacing glutathione with N-acetyl-L-cysteine.
    Yildiz D
    Med Hypotheses; 2004; 63(1):80-2. PubMed ID: 15193353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery.
    de Souza AC; Justo GZ; de Araújo DR; Cavagis AD
    Cell Physiol Biochem; 2011; 28(5):771-92. PubMed ID: 22178931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism 2014--alterations of metabolic pathways as therapeutic targets.
    Ji S; Kim J; Orlikova B; Diederich M
    Biochem Pharmacol; 2014 Nov; 92(1):1-2. PubMed ID: 25219325
    [No Abstract]   [Full Text] [Related]  

  • 33. Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells.
    Marbaniang C; Kma L
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2377-2390. PubMed ID: 30255690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary dynamics of the Warburg effect: glycolysis as a collective action problem among cancer cells.
    Archetti M
    J Theor Biol; 2014 Jan; 341():1-8. PubMed ID: 24075895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy.
    Ghasemishahrestani Z; Melo Mattos LM; Tilli TM; Santos ALSD; Pereira MD
    Curr Med Chem; 2021; 28(18):3514-3534. PubMed ID: 32814521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How cancer metabolism is tuned for proliferation and vulnerable to disruption.
    Schulze A; Harris AL
    Nature; 2012 Nov; 491(7424):364-73. PubMed ID: 23151579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In search for symmetries in the metabolism of cancer.
    Gatto F; Nielsen J
    Wiley Interdiscip Rev Syst Biol Med; 2016; 8(1):23-35. PubMed ID: 26538017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect.
    Sun L; Suo C; Li ST; Zhang H; Gao P
    Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):51-66. PubMed ID: 29959989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proliferation of Drosophila in cancer research: a system for the functional characterization of tumor suppressors and oncogenes.
    Rabinow L
    Cancer Invest; 2002; 20(4):531-56. PubMed ID: 12094549
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA Tumor Viruses and Cell Metabolism.
    Mushtaq M; Darekar S; Kashuba E
    Oxid Med Cell Longev; 2016; 2016():6468342. PubMed ID: 27034740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.